Aim: Gastrointestinal stromal tumors (GISTs) are rare. GISTs differ from other mesenchymal tumors of the gastrointestinal tract (e.g. leiomyomas and schwannomas). The purpose of this study was to investigate the role of Ets-1 in the growth and differentiation of GISTs.
Methods: Twenty-eight GISTs, nine leiomyomas and six schwannomas were examined by immunohistochemical staining method for Ets-1 in this study. Specimens were selected from surgical pathology archival tissues at Nagasaki University Hospital.
Results: Ets-1 protein was expressed in the cytoplasm of cells in all of these tumors. Immunohistochemical staining revealed that 27 GISTs (96.4%), six leiomyomas (66.7%), and five schwannomas (83.3%) were positive for Ets-1. Ets-1 expression was statistically different between GISTs and leiomyomas (P<0.005). However, there was no correlation between Ets-1 expression and clinical risk categories.
Conclusion: Ets-1 plays an important role in the growth and differentiation of GISTs, leiomyomas and schwannomas.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124350 | PMC |
| http://dx.doi.org/10.3748/wjg.v12.i11.1743 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Traction-assisted endoscopic ultrasound-guided fine-needle biopsy using the clip-with-thread method for small gastric subepithelial lesions: Randomized controlled trial (with video).
Dig Endosc
January 2025
Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Objectives: Endoscopic ultrasound-guided fine-needle aspiration/biopsy (EUS-FNA/B) is the gold standard for diagnosing gastric subepithelial lesions (SELs), but diagnosing lesions smaller than 20 mm remains challenging. We developed traction-assisted EUS-FNB (TA-EUS-FNB) using the clip-with-thread method to enhance diagnostic accuracy by stabilizing the lesion and providing counter-traction for easier needle access. This study evaluates the effectiveness of TA-EUS-FNB in diagnosing small gastric SELs.
View Article and Find Full Text PDFThe diagnostic value of endoscopic ultrasound for esophageal subepithelial lesions: A review.
Medicine (Baltimore)
November 2024
Department of Thoracic Surgery, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Article Synopsis
- Esophageal subepithelial lesions (ESELs) include a range of tumors and diseases, such as leiomyomas and hemangiomas, often going undetected due to asymptomatic presentations.
- Common imaging methods for ESEL diagnosis involve conventional endoscopy, spiral computed tomography, and endoscopic ultrasound (EUS), with EUS being the most accurate.
- Recent advancements in EUS technology, including artificial intelligence and enhanced imaging techniques, have improved diagnostic accuracy for ESELs and helped reduce missed cases.
Minimally invasive resection of a giant esophageal schwannoma.
Pak J Med Sci
November 2024
Muneeba Sohail, MBBS Dow Medical College, Dow University of Health Sciences, Karachi-74200, Pakistan.
Benign tumors of the esophagus are uncommon, and primary esophageal schwannoma of the esophagus is even rarer, accounting for 2% of cases. Less than 30 cases have been reported in the literature. Here we report a case of a young man with a symptomatic giant esophageal schwannoma, which was completely removed by laparoscopic three-staged esophagectomy.
View Article and Find Full Text PDFEndoscopic "calabash" ligation and resection for small gastric mesenchymal tumors.
World J Gastrointest Endosc
October 2024
Department of Gastroenterology, Shenzhen People's Hospital, The Second Clinical Medical College, Jinan University, Shenzhen 518000, Guangdong Province, China.
Background: Gastric mesenchymal tumors (GMT) are identified as soft tissue neoplasms that arise from mesenchymal stem cells within the gastrointestinal tract. GMT primarily encompass gastric stromal tumors (GST), gastric leiomyomas, and gastric schwannomas. Although most GMT are benign, there are still potential malignant changes, especially GST.
View Article and Find Full Text PDFHead-to-Head Comparison of [Ga]Ga-NOTA-RM26 and [F]FDG PET/CT in Patients with Gastrointestinal Stromal Tumors: A Prospective Study.
J Nucl Med
October 2024
Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore;
Gastrointestinal stromal tumors (GISTs) are the most common stromal tumors in the gastrointestinal tract. This study was designed to evaluate a gastrin-releasing peptide receptor antagonist PET tracer, [Ga]Ga-NOTA-RM26, and compare it with [F]FDG PET/CT in the assessment of patients with GISTs. With institutional review board approval and informed consent, 30 patients with suspected or proven GISTs based on abdominal CT or gastroscopy were recruited.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!